|
private:texasamericanresources-2
|
1290731
|
Jun 3rd, 2019 12:00AM
|
Texas American Resources Company
|
1.6K
|
37.00
|
Open
|
Oil & Energy
|
Jun 3rd, 2019 07:29PM
|
Jun 3rd, 2019 07:29PM
|
Texas American Resources Company is a privately held, independent oil & gas exploration & production company headquartered in Austin, Texas. The company was founded in 1990 by President and CEO, David E. Honeycutt, and currently owns, manages, and operates producing and developable Eagle Ford and Austin Chalk assets in South Texas. As a multi-disciplined team specializing in geology, engineering, finance, and land, TARC uses a subsurface driven approach, utilizing the latest technology to maximize the recovery of hydrocarbons in an efficient and a responsible manner.
In December 2016, TARC partnered with First Reserve, a leading global private equity investment firm exclusively focused on energy, in order to support the company’s pursuit of oil development opportunities in the Eagle Ford Shale. In conjunction with the closing of this partnership, TARC acquired an initial leasehold position in the black oil window of the Eagle Ford trend in Atascosa County, Texas, covering ~12,000 acres. With First Reserve, TARC plans to acquire and develop a portfolio of properties that combines existing production with significant remaining undrilled locations.
TARC previously operated in the DJ Basin in Colorado and Wyoming, the Barnett Shale in North Texas, in East Texas, the Texas Panhandle, and the Texas Gulf Coast, where the company successfully grew production and reserves, resulting in attractive returns for its partners and investors.
|
Open
|
|
Open
|
201 W 5th St, 1300
|
Austin
|
Texas
|
US
|
78701
|
|
Texas American Resources
|
|
Pharmaceuticals & Biotechnology
|
|
private:texasamericanresources-2
|
1290731
|
Mar 12th, 2018 12:00AM
|
Texas American Resources
|
1.5K
|
42.00
|
Open
|
Oil & Energy
|
Mar 12th, 2018 01:49PM
|
Mar 12th, 2018 01:49PM
|
|
Open
|
|
|
|
|
|
|
|
|
Texas American Resources
|
|
Pharmaceuticals & Biotechnology
|
|
private:texasamericanresources-2
|
1290731
|
Nov 7th, 2017 12:00AM
|
Texas American Resources
|
1.4K
|
42.00
|
Open
|
Oil & Energy
|
Nov 7th, 2017 04:21PM
|
Nov 7th, 2017 04:21PM
|
Texas American Resources Company, (“TARC”), is a privately held, independent energy company headquartered in Austin, Texas. The company was founded in 1990 by President and CEO, David E. Honeycutt. Historically, TARC has engaged in acquisitions and exploitation strategies while operating in Texas, Colorado and Wyoming.
Currently, the company is solely operating in South Texas and in the Texas Panhandle. TARC is very successful in acquiring assets within older fields, creating value through lease operating efficiencies and developing new drilling opportunities. Texas American Resources is an oil-focused company, exclusively utilizing the horizontal well strategy. TARC’s approach is a combined tactic of strategic acquisitions and growth through the drill-bit.
|
|
|
|
|
|
|
|
|
|
Texas American Resources
|
|
Pharmaceuticals & Biotechnology
|
|
private:texasamericanresources-2
|
1290731
|
Nov 1st, 2017 12:00AM
|
Texas American Resources
|
1.4K
|
42.00
|
Open
|
Oil & Energy
|
Nov 1st, 2017 04:08AM
|
Nov 1st, 2017 04:08AM
|
Texas American Resources Company, (“TARC”), is a privately held, independent energy company headquartered in Austin, Texas. The company was founded in 1990 by President and CEO, David E. Honeycutt. Historically, TARC has engaged in acquisitions and exploitation strategies while operating in Texas, Colorado and Wyoming.
Currently, the company is solely operating in South Texas and in the Texas Panhandle. TARC is very successful in acquiring assets within older fields, creating value through lease operating efficiencies and developing new drilling opportunities. Texas American Resources is an oil-focused company, exclusively utilizing the horizontal well strategy. TARC’s approach is a combined tactic of strategic acquisitions and growth through the drill-bit.
|
|
|
|
|
|
|
|
|
|
Texas American Resources
|
|
Pharmaceuticals & Biotechnology
|